Sort by
Refine Your Search
-
infrastructure for quantitative proteomics, molecular and functional genomics, bioimaging, and experimental model systems. The position is embedded in the Protein Research Group, which focuses on quantitative
-
Two Postdoctoral Positions (f/m/d) in Bioengineering / Systems Biology and Yeast and Mammalian Cell Engineering (full-time) Center for Molecular Biology of Heidelberg University (ZMBH), Heidelberg
-
of molecular systems have until now only been studied with highly abstracted models. A more detailed modeling approach, inspired on the engineering-type approaches used in molecular systems biology, is needed
-
at the systems level. By integrating groundbreaking multiomic methods at the single-cell level with advanced experimental models, such as human organoids, the laboratory maps the molecular and cellular mechanisms
-
discipline Strong experience in integrating several of the following components: Deep learning and LLMs for molecular biology Vision foundation models for pathological image analysis Multi-omics datasets (e.g
-
to predict bacterial growth from protein sequence and compound molecular structure. Applying generative and predictive models to propose novel compounds optimized for broad-spectrum activity against diverse
-
molecular biology and immunology techniques along with multi-omics approaches, including sc-RNA-seq, bulk RNAseq, epigenomics, metabolomics, proteomics, CRISPR screens and genetically engineered mouse models
-
to define their molecular mechanisms, elucidate their roles in aging and neurodegenerative diseases (including Alzheimer’s disease, Parkinson’s disease, and ALS), and explore their potential as targets
-
of cell and molecular biology approaches, including high-throughput functional genomics and drug screening, gene expression and analyses in tissue culture cells, murine models of cancer, and genomics
-
personalized immunotherapies for cancer patients with brain metastasis. Our group works at the interface between immunology and cancer biology combining the use of preclinical models of cancer and human samples